A double blind, multiclinic trial of sulindac (MG 213) in the treatment of ankylosing spondylitis

M. R. Liebling, R. D. Altman, T. G. Benedek

Research output: Contribution to journal › Article › peer-review

11 Scopus citations

Fingerprint

Dive into the research topics of 'A double blind, multiclinic trial of sulindac (MG 213) in the treatment of ankylosing spondylitis'. Together they form a unique fingerprint.